Literature DB >> 19116634

Can type VII collagen injections cure dystrophic epidermolysis bullosa?

Leena Bruckner-Tuderman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19116634      PMCID： PMC2834980          DOI： 10.1038/mt.2008.262

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

Review 1.  Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa.

Authors:  L Bruckner-Tuderman; B Höpfner; N Hammami-Hauasli
Journal:  Matrix Biol       Date:  1999-02       Impact factor: 11.583

Review 2.  Molecular basis of inherited skin-blistering disorders, and therapeutic implications.

Authors:  Monique Aumailley; Cristina Has; Lucy Tunggal; Leena Bruckner-Tuderman
Journal:  Expert Rev Mol Med       Date:  2006-10-13       Impact factor: 5.600

3.  Proteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagen.

Authors:  Anke Rattenholl; William N Pappano; Manuel Koch; Douglas R Keene; Karl E Kadler; Takako Sasaki; Rupert Timpl; Robert E Burgeson; Daniel S Greenspan; Leena Bruckner-Tuderman
Journal:  J Biol Chem       Date:  2002-05-01       Impact factor: 5.157

4.  Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.

Authors:  Cassian Sitaru; Sidonia Mihai; Christoph Otto; Mircea T Chiriac; Ingrid Hausser; Barbara Dotterweich; Hitoshi Saito; Christian Rose; Akira Ishiko; Detlef Zillikens
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

5.  Tissue-specific expression and long-term deposition of human collagen VII in the skin of transgenic mice: implications for gene therapy.

Authors:  E Sat; K H Leung; L Bruckner-Tuderman; K S Cheah
Journal:  Gene Ther       Date:  2000-10       Impact factor: 5.250

6.  Expanding the COL7A1 mutation database: novel and recurrent mutations and unusual genotype-phenotype constellations in 41 patients with dystrophic epidermolysis bullosa.

Authors:  Johannes S Kern; Jürgen Kohlhase; Leena Bruckner-Tuderman; Cristina Has
Journal:  J Invest Dermatol       Date:  2006-05       Impact factor: 8.551

7.  Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors.

Authors:  Christine Baldeschi; Yannick Gache; Anke Rattenholl; Pascale Bouillé; Olivier Danos; Jean-Paul Ortonne; Leena Bruckner-Tuderman; Guerrino Meneguzzi
Journal:  Hum Mol Genet       Date:  2003-08-01       Impact factor: 6.150

8.  Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.

Authors:  Jennifer Remington; Xinyi Wang; Yingpin Hou; Hui Zhou; Julie Burnett; Trevor Muirhead; Jouni Uitto; Douglas R Keene; David T Woodley; Mei Chen
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

9.  Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

Authors:  Fulvio Mavilio; Graziella Pellegrini; Stefano Ferrari; Francesca Di Nunzio; Enzo Di Iorio; Alessandra Recchia; Giulietta Maruggi; Giuliana Ferrari; Elena Provasi; Chiara Bonini; Sergio Capurro; Andrea Conti; Cristina Magnoni; Alberto Giannetti; Michele De Luca
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

10.  Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa.

Authors:  S Heinonen; M Männikkö; J F Klement; D Whitaker-Menezes; G F Murphy; J Uitto
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285
View more
  5 in total

1.  Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

Authors:  Johannes S Kern; Stefan Loeckermann; Anja Fritsch; Ingrid Hausser; Wera Roth; Thomas M Magin; Claudia Mack; Marcel L Müller; Oliver Paul; Patrick Ruther; Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

Review 2.  Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.

Authors:  Christopher Perdoni; Mark J Osborn; Jakub Tolar
Journal:  Transl Res       Date:  2015-05-27       Impact factor: 7.012

Review 3.  Collagens.

Authors:  Marion K Gordon; Rita A Hahn
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

Review 4.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

5.  Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen.

Authors:  Katarzyna Osipowicz; Piotr Wychowanski; Pawel Nieckula; Sara Shamsa; Katarzyna Wertheim-Tysarowska; Katarzyna Wozniak; Cezary Kowalewski
Journal:  Postepy Dermatol Alergol       Date:  2020-07-14       Impact factor: 1.837
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.